Back to search

Boston University

A pax of all trades: discovering a novel role for the transcription factor paired box 3 as a promoter of nonsense mediated decay

Abstract

dc:description.abstract

The main canonical function of Paired Box 3 (PAX3) is to act as a transcription factor, where it drives development in the neural crest and neural-crest derived tissues. PAX3 is downregulated as development continues but is frequently upregulated in melanoma. In the context of melanoma, PAX3 has been assumed to drive cancer progression by transcriptionally activating genes that improve tumor survivability and invasion. However, this known role may not fully explain the wide impact of PAX3 on melanoma progression (growth, survival, migration, inhibition of differentiation) and may be due to other, non-characterized roles. We discovered PAX3 interaction with RNA-processing proteins, most notably exon junction complex (EJC) and RNA degradation proteins, indicating a possible connection to nonsense-mediated decay (NMD). NMD is an RNA quality-control and regulation pathway that degrades mRNAs containing premature termination codons. PAX3 overexpression was shown to increase NMD activity by multiple metrics. This includes a reduction in RNA of known NMD-targeted transcripts and reduction in signal in an NMD-targeted reporter system, indicating that PAX3 was improving degradation of transcripts that are vulnerable to NMD-targeting. Further, PAX3 overexpression also increased UPF1 phosphorylation, an early marker of NMD activation, indicating that PAX3 is a positive regulator of NMD. PAX3-NMD was not reliant on RNA binding, splicing alterations, or transcriptional activity, supporting that PAX3-mediated NMD is driven through protein-protein interactions. PAX3-NMD functions to suppress apoptotic and tumor-suppressor pathways that drive melanoma survival and growth, as supported by transcriptome analysis. Deletion and mutation of the PAX3 protein established that PAX3-NMD activity is not dependent on PAX3’s transcriptional domains or previously described regulatory regions. Instead, PAX3-NMD activity appears to be dependent on a previously uncharacterized polar region that may be a site for protein-protein interactions. Deletion of the polar region removes PAX3’s ability to drive NMD without affecting transcriptional activity. Here, we find a novel and transcriptionally independent function of PAX3 in promoting melanoma progression by acting through the NMD pathway. The main canonical function of Paired Box 3 (PAX3) is to act as a transcription factor, where it drives development in the neural crest and neural-crest derived tissues. PAX3 is downregulated as development continues but is frequently upregulated in melanoma. In the context of melanoma, PAX3 has been assumed to drive cancer progression by transcriptionally activating genes that improve tumor survivability and invasion. However, this known role may not fully explain the wide impact of PAX3 on melanoma progression (growth, survival, migration, inhibition of differentiation) and may be due to other, non-characterized roles. We discovered PAX3 interaction with RNA-processing proteins, most notably exon junction complex (EJC) and RNA degradation proteins, indicating a possible connection to nonsense-mediated decay (NMD). NMD is an RNA quality-control and regulation pathway that degrades mRNAs containing premature termination codons. PAX3 overexpression was shown to increase NMD activity by multiple metrics. This includes a reduction in RNA of known NMD-targeted transcripts and reduction in signal in an NMD-targeted reporter system, indicating that PAX3 was improving degradation of transcripts that are vulnerable to NMD-targeting. Further, PAX3 overexpression also increased UPF1 phosphorylation, an early marker of NMD activation, indicating that PAX3 is a positive regulator of NMD. PAX3-NMD was not reliant on RNA binding, splicing alterations, or transcriptional activity, supporting that PAX3-mediated NMD is driven through protein-protein interactions. PAX3-NMD functions to suppress apoptotic and tumor-suppressor pathways that drive melanoma survival and growth, as supported by transcriptome analysis. Deletion and mutation of the PAX3 protein established that PAX3-NMD activity is not dependent on PAX3’s transcriptional domains or previously described regulatory regions. Instead, PAX3-NMD activity appears to be dependent on a previously uncharacterized polar region that may be a site for protein-protein interactions. Deletion of the polar region removes PAX3’s ability to drive NMD without affecting transcriptional activity. Here, we find a novel and transcriptionally independent function of PAX3 in promoting melanoma progression by acting through the NMD pathway.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Molecular and Translational Medicine
Grantor
Boston University
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Prince, Noah Barnes
Advisor dc:contributor.advisor
  • Lang, Deborah

Subjects

dc:subject × 8

Rights

dc:rights
Statement dc:rights
  • Attribution 4.0 International
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/53463

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Prince, Noah Barnes. A pax of all trades: discovering a novel role for the transcription factor paired box 3 as a promoter of nonsense mediated decay. doctoral thesis, Boston University, 2026. https://hdl.handle.net/2144/53463